Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32-35 Weeks Gestation Not Receiving Immunoprophylaxis
Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32-35 Weeks Gestation Not Receiving Immunoprophylaxis
复制标题
DOI:
10.1097/inf.0000000000000219
复制
发表时间:
2014-06-01
影响因子:
3.6
通讯作者:
Groothuis, Jessie R.
中科院分区:
文献类型:
--
作者:
Ambrose, Christopher S.;Anderson, Evan J.;Groothuis, Jessie R.
Background: The Respiratory Syncytial Virus (RSV) Respiratory Events Among Preterm Infants Outcomes and Risk Tracking (REPORT) study evaluated RSV disease burden in US preterm infants 32-35 weeks gestational age (wGA) not receiving RSV prophylaxis.Methods: Preterm infants